 |
 |
|
|
RESÚMENES ABRIL 2009 |
Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers
(Haga un click
en la información del journal para acceder al resúmen)
5 – doble-ciego o
metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 –
casos; 1 – opinión
GRATIS = Texto gratuito en algunos países de la región iberoamericana
(algunos artículos requieren ir a la tabla de contenidos del
número actual de la revista)
5 - Maintenance Treatment for Patients With Bipolar I Disorder: Results From a North American Study
of Quetiapine in Combination With Lithium or Divalproex (Trial 127)
Trisha Suppes, Eduard Vieta, Sherry Liu, Martin Brecher, and Björn
Paulsson
Am J
Psychiatry 2009; 166:476-488
3! - Long-Term
Use of Antidepressants for Depressive Disorders and the Risk of Diabetes
Mellitus
Frank Andersohn, René Schade,
Samy Suissa, and Edeltraut Garbe
Am J Psychiatry Published April 1, 2009
3! - Can
Phase III Trial Results of Antidepressant Medications Be Generalized to
Clinical Practice? A STAR*D Report
Stephen R. Wisniewski, A. John
Rush, Andrew A. Nierenberg, Bradley N. Gaynes, Diane Warden, James F. Luther,
Patrick J. McGrath, Philip W. Lavori, Michael E. Thase, Maurizio Fava, and
Madhukar H. Trivedi
Am J Psychiatry Published April 1, 2009
3 - Neuroticism, introversion, and major depressive
disorder - traits, states, or scars?
Pekka Jylhä, Tarja Melartin, Heikki Rytsälä, Erkki Isometsä
Depression and Anxiety. Volume 26 Issue 4, Pages 325 - 334
3 - Temperament
and character traits in major depressive disorder: influence of mood state and
recurrence of episodes
Fabiano G. Nery, John P. Hatch, Mark A. Nicoletti, E. Serap Monkul,
Pablo Najt, Koji Matsuo, C. Robert Cloninger, Jair C. Soares
Depression and Anxiety. Volume 26 Issue 4, Pages 382 - 388
3! - A
population-based family study of minor depression
Stephen C. Newman, Roger C. Bland
Depression and Anxiety. Volume 26 Issue 4, Pages 389 - 392
3! - Teratogenesis associated with antibipolar agents
Ha T. T. Nguyen, Verinder Sharma and
Roger S. McIntyre
Advances in Therapy. OnLine First. March 2009
3 - Inhibitory
effect of selective serotonin reuptake inhibitors on the vesicular monoamine
transporter 2
Satoshi Yasumoto, Kohei Tamura, Junichi Karasawa, Ryota Hasegawa,
Kazutaka Ikeda, Toshifumi Yamamoto and Hideko Yamamoto
Neuroscience
Letters. Volume 454, Issue 3, 1 May 2009, Pages 229-232
3 -
Topiramate in Combat-Related Posttraumatic Stress Disorder
Christopher P Alderman, Linda C
McCarthy, John T Condon, Anita C Marwood, Judith R Fuller
The
Annals of Pharmacotherapy: Vol. 43, No. 4, pp. 635-641
3 - Coherences Between
the Metabolic Syndrome, Depression, Stress and Physical Activity
Norbert-Ullrich Neumann, Karel Frasch
Psychiat Prax 2009; 36: 110-114
3! - Lithium-induced suicidal erythrocyte death
JP
Nicolay,
Journal of Psychopharmacology First
published on April 3, 2009
3 - Long-term anxiolytic and antidepressant-like
behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1)
inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice
CK
Thoeringer, A Erhardt, I
Journal of Psychopharmacology First
published on April 3, 2009
3! - Proteomic analysis of rat hippocampus exposed to the
antidepressant paroxetine
PC
McHugh, GR Rogers, DM Glubb, PR Joyce, and MA Kennedy
Journal of Psychopharmacology First
published on April 3, 2009
3! -
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology
of Major Depression
Andrew H. Miller, Vladimir Maletic and Charles
L. Raison
Biological Psychiatry. Volume 65, Issue 9, 1 May
2009, Pages 732-741
3! - Selective Serotonin
Reuptake Inhibitors Modify Physiological Gastrointestinal Motor Activities via
5-HT2c Receptor and Acyl Ghrelin
Naoki Fujitsuka,
Akihiro Asakawa, Mizuki Hayashi, Marie Sameshima, Haruka Amitani, Shinya
Kojima, Mineko Fujimiya and Akio Inui
Biological Psychiatry. Volume 65, Issue 9, 1 May 2009, Pages 748-759
3! -
Variation in Catechol-O-Methyltransferase
Is Associated with Duloxetine Response in a Clinical Trial for Major Depressive
Disorder
Roy H. Perlis, Bonnie Fijal, David H. Adams, Virginia K. Sutton, Madhukar
H. Trivedi and John P. Houston
Biological Psychiatry. Volume 65, Issue 9, 1 May
2009, Pages 785-791
3! - Amygdala
Volume Marks the Acute State in the Early Course of Depression
Philip van Eijndhoven, Guido van Wingen, Koen van Oijen, Mark Rijpkema,
Bozena Goraj, Robbert Jan Verkes, Richard Oude Voshaar, Guillén Fernández, Jan
Buitelaar and Indira Tendolkar
Biological Psychiatry. Volume 65, Issue 9, 1 May
2009, Pages 812-818
3! - Mood
stabilizing drugs lamotrigine and olanzapine increase expression and activity
of glutathione s-transferase in primary cultured rat cerebral cortical cells
Adedolapo Bakare, Li Shao, Jie Cui, L. Trevor Young and Jun-Feng Wang
Neuroscience
Letters. Volume 455, Issue 1, 8 May 2009, Pages 70-73
3 - Identifying
predictors for good lithium response – A retrospective analysis of 100 patients
with bipolar disorder using a life-charting method
Lena Backlund, Anna
Ehnvall, Jerker Hetta, Göran Isacsson and Hans Ågren
European Psychiatry. Volume
24, Issue 3, April 2009, Pages 171-177
3 - Neurocognitive
functions in euthymic bipolar patients
K. Jamrozinski, O. Gruber, C. Kemmer, P. Falkai, H. Scherk
Acta Psychiatrica Scandinavica. Volume
119 Issue 5, Pages 365 - 374
3! - Length
of Time Between Onset of Childhood Sexual Abuse and
Emergence of Depression in a Young Adult Sample: A Retrospective Clinical
Report
Martin H. Teicher,
Jacqueline A. Samson, Ann Polcari, and Susan L. Andersen
J Clin Psychiatry April 7, 2009: e1-e8
3! - Impact
of Antidepressant Continuation After Acute Positive or
Partial Treatment Response for Bipolar Depression: A Blinded, Randomized Study
Lori L. Altshuler, Robert M. Post, Gerhard
Hellemann, Gabriele S. Leverich, Willem A. Nolen, Mark A. Frye, Paul E. Keck,
Jr., Ralph W. Kupka, Heinz Grunze, Susan L. McElroy, Catherine A. Sugar, and
Trisha Suppes
J Clin Psychiatry 2009;70(4): 450-457
5 - Extended Release Quetiapine Fumarate
Monotherapy in Major Depressive Disorder: A Placebo- and Duloxetine-Controlled
Study
Andrew
J. Cutler, Stuart A. Montgomery, David Feifel, Arthur Lazarus, Mikael Åström,
and Martin Brecher
J
Clin Psychiatry 2009;70(4):526-539
5 -
Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder: Results of a Randomized,
Placebo-Controlled, Double-Blind Study
Michael Bauer, Herman W. Pretorius, Eric L.
Constant, Willie R. Earley, Johan Szamosi, and Martin Brecher
J
Clin Psychiatry 2009;70(4):540-549
5 - A
Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of
Venlafaxine Extended Release Capsules in Adult Outpatients With
Panic Disorder
Michael R. Liebowitz, Gregory Asnis, Richard
Mangano, and Evan Tzanis
J
Clin Psychiatry 2009;70(4):550-561
3! - Duloxetine in the management of elderly patients with
major depressive disorder: an analysis of published data
M Mancini
, W Gianni, A Rossi &
M
Amore
Expert Opinion on Pharmacotherapy. April 2009, Vol. 10, No. 5, Pages 847-860
3 - NMDA receptor antagonists augment antidepressant-like
effects of lithium in the mouse forced swimming test
M
Ghasemi, M Raza, and AR Dehpour
Journal of Psychopharmacology First
published on April 7, 2009
3 - High-dose selective serotonin reuptake inhibitors in
OCD: a systematic retrospective case notes survey
I Pampaloni, T Sivakumaran, CJ Hawley, A Al Allaq, J
Farrow, S Nelson, and NA Fineberg
Journal of
Psychopharmacology First published on April 7, 2009
3 -
Heterogeneity in Comorbidity Between Major Depressive
Disorder and Generalized Anxiety Disorder and Its Clinical Consequences
Unick, George J;
Snowden, Lonnie; Hastings, Julia
The
Journal of Nervous and Mental Disease: April 2009 - Volume 197 - Issue 4 - pp
215-224
3! - Gender differences in the association
between antidepressant use and restless legs syndrome
Kristin R. Baughman, Claire C. Bourguet,
Scott K. Ober
Movement Disorders. Published Online: 7 Apr 2009
4 - Baseline
severity of depression predicts antidepressant drug response relative to
escitalopram
, Alan G Wade, Henning F Andersen & Thomas E Schlaepfer
Expert Opinion on
Pharmacotherapy. April 2009, Vol. 10, No. 6, Pages 927-936
5 -
Anxiety does not predict response to antidepressant treatment in late life
depression: results of a meta-analysis
J. Craig Nelson, Kevin Delucchi, Lon S.
Schneider
International Journal of Geriatric Psychiatry. Volume
24 Issue 5, Pages 539 - 544
3! - History of Depression and Survival After
Acute Myocardial Infarction
Robert
M. Carney, Kenneth E. Freedland, Brian Steinmeyer, James A. Blumenthal, Peter
de Jonge, Karina W. Davidson, Susan M. Czajkowski, and Allan S. Jaffe
Psychosomatic Medicine 71:253-259 (2009)
3! - Lifetime History of Major
Depression Predicts the Development of the Metabolic Syndrome in Middle-Aged
Women
Edie
M. Goldbacher, Joyce Bromberger, and Karen A. Matthews
Psychosomatic Medicine 71:266-272 (2009)
3! - Major Depression as a Risk Factor for High
Blood Pressure: Epidemiologic Evidence From a National Longitudinal Study
Scott
B. Patten, Jeanne V. A. Williams, Dina H. Lavorato, Norman R. C. Campbell,
Michael Eliasziw, and Tavis S. Campbell
Psychosomatic Medicine 71:273-279 (2009)
3! - Corticolimbic Transcriptome Changes are
State-Dependent and Region-Specific in a Rodent Model of Depression and of
Antidepressant Reversal
Alexandre Surget,
Yingjie Wang, Samuel Leman, Yadira Ibarguen-Vargas,
Nicole Edgar, Guy Griebel, Catherine Belzung and
Etienne Sibille
Neuropsychopharmacology (2009) 34,
1363–1380
3! - Evidence for Selective microRNAs and
Their Effectors as Common Long-Term Targets for the Actions of Mood Stabilizers
Rulun Zhou,
Peixiong Yuan, Yun Wang, Joshua G Hunsberger,
Abdel Elkahloun, Yanling Wei, Patricia Damschroder-Williams,
Jing Du, Guang Chen and Husseini K Manji
Neuropsychopharmacology (2009) 34,
1395–1405
3! - Association of Changes in Norepinephrine
and Serotonin Transporter Expression with the Long-Term Behavioral Effects of
Antidepressant Drugs
Zaorui Zhao,
Han-Ting Zhang, Elianna Bootzin, Mark J Millan and James
M O'Donnell
Neuropsychopharmacology (2009) 34,
1467–1481
3 - Acute Stress Responsiveness of the
Neurotrophin BDNF in the Rat Hippocampus is Modulated by Chronic Treatment with
the Antidepressant Duloxetine
Raffaella Molteni,
Francesca Calabrese, Annamaria Cattaneo, Michele Mancini,
Massimo Gennarelli, Giorgio Racagni and Marco A Riva
Neuropsychopharmacology (2009) 34,
1523–1532
5 - A Double-Blind, Placebo-Controlled,
Parallel-Group, Flexible-Dose Study of Venlafaxine Extended Release Capsules in
Adult Outpatients With Panic Disorder
Michael R. Liebowitz, Gregory Asnis, Richard
Mangano, and Evan Tzanis
J Clin Psychiatry April 7, 2009: e1-e12
3 - Is the significant superiority of
escitalopram compared with other antidepressants clinically relevant?
Montgomery, Stuart
A.; Möller, Hans-Jürgen
International
Clinical Psychopharmacology: May 2009 - Volume 24 - Issue 3 - pp 111-118
3! - Differences in the dynamics of serotonin
reuptake transporter occupancy may explain superior clinical efficacy of
escitalopram versus citalopram
Dudczak, Robert;
Kasper, Siegfried; Sacher, Julia; Klein, Nikolas; Mossaheb, Nilufar;
Attarbaschi-Steiner, Trawat; Lanzenberger, Rupert; Spindelegger, Christoph;
Asenbaum, Susanne; Holik, Alexander
International
Clinical Psychopharmacology: May 2009 - Volume 24 - Issue 3 - pp 119-125
4 - Impact of gastrointestinal symptoms on
response to pregabalin in generalized anxiety disorder: results of a six-study
combined analysis
Stein, Dan J.;
Bruce Lydiard, R.; Herman, Barry K.; Mandel, Francine S
International
Clinical Psychopharmacology: May 2009 - Volume 24 - Issue 3 - pp 126-132
4 - Remission, response without remission, and
nonresponse in major depressive disorder: impact on functioning
Trivedi, Madhukar
H.; Corey-Lisle, Patricia K.; Guo, Zhenchao; Lennox, Richard D.; Pikalov,
Andrei; Kim, Edward
International
Clinical Psychopharmacology: May 2009 - Volume 24 - Issue 3 - pp 133-138
3! - Adverse event load in bipolar participants
receiving either carbamazepine immediate-release or extended-release capsules:
a blinded, randomized study
El-Mallakh, Rif
S.; Salem, Mary Ruth; Chopra, Amarjit S.; Mickus, Gregory J.; Penagaluri,
Praveen
International
Clinical Psychopharmacology: May 2009 - Volume 24 - Issue 3 - pp 145-149
3! -
Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic
Drugs
Kimford J.
Meador, Gus A. Baker, Nancy Browning, Jill Clayton-Smith, Deborah T.
Combs-Cantrell, Morris Cohen, Laura A. Kalayjian, Andres Kanner, Joyce D.
Liporace, Page B. Pennell, Michael Privitera, David W. Loring, for the NEAD
Study Group
NEJM. Volume 360:1597-1605; April 16, 2009, Number 16
3! -
Persistence of abnormal cortisol levels in elderly persons after recovery from
major depression
Isabelle Beluche, Isabelle Chaudieu, Joanna Norton, Isabelle Carrière,
Jean-Philippe Boulenger, Karen Ritchie and Marie L. Ancelin
Journal of Psychiatric
Research. Volume 43, Issue 8, May 2009, Pages 777-783
3< -
Therapeutic effects of escitalopram and reboxetine in seasonal affective
disorder: A pooled analysis
Edda Pjrek,
Anastasios Konstantinidis, Eva Assem-Hilger, Nicole Praschak-Rieder, Matthäus
Willeit, Siegfried Kasper and Dietmar Winkler
Journal of Psychiatric
Research. Volume 43, Issue 8, May 2009, Pages 792-797
3 -
Increased depressive symptoms in menopausal age women with bipolar disorder:
Age and gender comparison
Wendy K. Marsh,
Terence A. Ketter and Natalie L. Rasgon
Journal of Psychiatric
Research. Volume 43, Issue 8, May 2009, Pages 798-802
3 - Reproductive Aging, Sex
Steroids, and Mood Disorders
Veronica Harsh; Samantha
Meltzer-Brody; David R. Rubinow; Peter J. Schmidt
Harvard Review of
Psychiatry, Volume 17, Issue 2 April 2009, pages 87 - 102
3 - Reproductive and Metabolic Abnormalities
Associated with Bipolar Disorder and Its Treatment
Heather A. Kenna; Bowen Jiang; Natalie
L. Rasgon
Harvard Review of
Psychiatry, Volume 17, Issue 2 April 2009, pages 138 - 146
3 - Na+,K+-ATPase
activity in an animal model of mania
Alexandra I. Zugno,
Samira S. Valvassori, Emilene B. S. Scherer,
Cristiane Mattos, Cristiane Matté, Camila L. Ferreira,
Gislaine T. Rezin, Angela T. S. Wyse,
João Quevedo and Emilio L. Streck
Journal of Neural Transmission. Volume 116, Number 4 /
April, 2009: 431-436
GRATIS 3! - Obsessive-compulsive
disorder: core interventions in the treatment of obsessive-compulsive disorder
and body dysmorphic disorder
National Collaborating Centre for Mental Health
GRATIS 3! -
MANAGEMENT OF OBSESSIVE COMPULSIVE DISORDER (OCD)
NATIONAL GUIDELINE CLEARINGHOUSE™ (NGC)
GUIDELINE SYNTHESIS
3 - Age at onset of first depressive episode as
a predictor for escitalopram treatment of major depression comorbid with
alcohol dependence
Leea H. Muhonen, Jouko Lönnqvist, Jari Lahti
and Hannu Alho
Psychiatry Research. Volume 167, Issues 1-2, 15 May 2009, Pages
115-122
3! -
Lithium: Updated Human Knowledge Using an
Evidence-Based Approach: Part II: Clinical Pharmacology and Therapeutic
Monitoring
Grandjean, Etienne Marc; Aubry, Jean-Michel
CNS Drugs. 23(4):331-349, 2009
3! - What predicts attrition in second step
medication treatments for depression?: a STAR*D Report
Diane Warden, A.
John Rush, Stephen R. Wisniewski, Ira M. Lesser, Susan G. Kornstein, G. K.
Balasubramani, Michael E. Thase, Sheldon H. Preskorn, Andrew A. Nierenberg,
Elizabeth A. Young, Kathy Shores-Wilson and Madhukar H. Trivedi
The
International Journal of Neuropsychopharmacology, Volume 12, Issue 04, May
2009, pp 459-473
3 - Long-term administration of monoamine
oxidase inhibitors alters the firing rate and pattern of dopamine neurons in
the ventral tegmental area
Franck Chenu,
Mostafa El Mansari and Pierre Blier
The
International Journal of Neuropsychopharmacology, Volume 12, Issue 04, May
2009, pp 475-485
3! - The antidepressant venlafaxine ameliorates
murine experimental autoimmune encephalomyelitis by suppression of
pro-inflammatory cytokines
Patrick Vollmar,
Stefan Nessler, Sudhakar Reddy Kalluri, Hans-Peter Hartung and Bernhard Hemmer
The
International Journal of Neuropsychopharmacology, Volume 12, Issue 04, May
2009, pp 525-536
3 - Premorbid adjustment: A phenotype highlighting a
distinction rather than an overlap between schizophrenia and bipolar disorder
Marcella Rietschel, Alexander Georgi, Christine Schmael, Frederike
Schirmbeck, Jana Strohmaier, Katja V. Boesshenz, Markus Schwarz, Markus M.
Nöthen and Thomas G. Schulze
Schizophrenia Research. Volume 110, Issues 1-3, May 2009, Pages
33-39
3! - Severe forms of depression: The efficacy of
escitalopram
C. Spadone
L'Encéphale. Volume 35, Issue 2, April 2009, Pages 152-159
3 - A UK consensus
on the administration of aripiprazole for the treatment of mania
KJ Aitchison, M Bienroth, J Cookson, R Gray, PM
Haddad, B Moore, L Ratna, G Sullivan, D Taylor, M Taylor, GM Goodwin
Journal
of Psychopharmacology, Vol. 23, No. 3, 231-240 (2009)
3 - Effect of
antidepressants on melatonin metabolite in depressed patients
LA Carvalho, C Gorenstein, R Moreno, C Pariante, RP
Markus
Journal
of Psychopharmacology, Vol. 23, No. 3, 315-321 (2009)
3 - Does oral
alprazolam affect ventilation? A randomised, double-blind, placebo-controlled
trial
GE Carraro, EW Russi, S Buechi, KE Bloch
Journal
of Psychopharmacology, Vol. 23, No. 3, 322-327 (2009)
3! - Bipolar I disorder with mood-incongruent
psychotic symptoms. A comparative longitudinal study
Andreas Marneros,
Stephan Röttig, Dörthe Röttig, Andrea Tscharntke and
Peter Brieger
5 - The effect of venlafaxine compared with
other antidepressants and placebo in the treatment of major depresión. A
meta-analysis
Michael Bauer,
Puvan Tharmanathan, Hans-Peter Volz, Hans-Juergen Moeller and
Nick Freemantle
3! - Electrocardiogram changes and arrhythmias in
venlafaxine overdose
Geoffrey K. Isbister
British Journal of Clinical Pharmacology. Volume 67 Issue
5, Pages 572 - 576
3! - Orosomucoid
influences the response to antidepressants in major depressive disorder
J Harley, R Roberts, P Joyce, R Mulder, S Luty, C
Frampton, and M Kennedy
Journal
of Psychopharmacology On Line First, April 2009
3 - Serotonin transporter promoter region
polymorphisms do not influence treatment response to escitalopram in patients
with major depression
Eduard Maron, Anu Tammiste, Kristi Kallassalu, Triin Eller, Veiko Vasar,
David J. Nutt and Andres Metspalu
European Neuropsychopharmacology. Volume 19, Issue 6, June
2009, Pages 451-456
3 - Beyond the monoaminergic hypothesis:
Agomelatine, a new antidepressant with an innovative mechanism of action
Siegfried Kasper; Michel Hamon
World
Journal of Biological Psychiatry, Volume 10, Issue 2 May 2009, pages 117 - 126
3! - Systemic Propranolol Acts Centrally to
Reduce Conditioned Fear in Rats Without Impairing Extinction
Jose Rodriguez-Romaguera, Francisco Sotres-Bayon, Devin Mueller and
Gregory J. Quirk
Biological Psychiatry. Volume 65, Issue 10, 15 May
2009, Pages 887-892
GRATIS 3! - Bipolar disorder. The
management of bipolar disorder in adults, children and adolescents, in primary
and secondary care
National Collaborating Centre for Mental Health
Leicester (UK): British Psychological Society, Royal
College of Psychiatrists; 2006. 592 p.
3 - A review of EEG and ERP studies in bipolar
disorder
Racheal Degabriele, Jim Lagopoulos
Acta Neuropsychiatrica. Volume 21 Issue
2, Pages 58 - 66
3! - Obesity and metabolic syndrome in Brazilian
patients with bipolar disorder
Karla Mathias de Almeida, Márcia B. de
Macedo-Soares, Cilly Kluger Issler, José Antonio Amaral, Sheila C. Caetano,
Rodrigo da Silva Dias, Beny Lafer
Acta Neuropsychiatrica. Volume 21 Issue
2, Pages 84 - 88
3! - Preclinical characterization of WAY-211612: a dual
5-HT uptake inhibitor and 5-HT1A receptor antagonist and potential
novel antidepressant
CE Beyer, Q Lin,
B Platt,
J Malberg,
G Hornby,
KM Sullivan,
DL Smith,
T Lock,
PJ Mitchell,
NT Hatzenbuhler,
DA Evrard,
BL Harrison,
R Magolda,
MN Pangalos,
LE Schechter,
S Rosenzweig-Lipson
and TH Andree
British Journal of Pharmacology. Volume 157 Issue
2, Pages 307 - 319
3! - A Longitudinal Study of the Effects of
Lithium Treatment on Prefrontal and Subgenual Prefrontal Gray Matter Volume in
Treatment-Responsive Bipolar Disorder Patients
Gregory J. Moore, Bernadette M. Cortese,
Debra A. Glitz, Caroline Zajac-Benitez, Jorge A. Quiroz, Thomas W. Uhde, Wayne
C. Drevets, and Husseini K. Manji
J Clin
Psychiatry April 21, 2009: e1-e7
GRATIS 3! -
Bipolar Disorder and Dopamine Dysfunction: An Indirect Approach Focusing on
Tardive Movement Syndromes in a naturalistic setting
Inge
van Rossum, Diederik
Tenback and Jim van Os
3 - Population pharmacokinetics of orally
administered duloxetine in patients: implications for dosing recommendation
Lobo ED, Quinlan T, O'Brien L,
Knadler MP, Heathman M
Clin Pharmacokinet. 2009;48(3):189-97
3! - The effect of antidepressant drugs on the HPA axis
activity, glucocorticoid receptor level and FKBP51 concentration in prenatally
stressed rats
Magdalena Szymańska, Bogusława Budziszewska,
Lucylla Jaworska-Feil, Agnieszka Basta-Kaim, Marta Kubera, Monika
Leśkiewicz, Magdalena Regulska and Władysław Lasoń
Psychoneuroendocrinology. Volume 34, Issue 6, July
2009, Pages 822-832
5< - A randomized controlled trial of intranasal
oxytocin as an adjunct to exposure therapy for social anxiety disorder
Adam J. Guastella,
Alexandra L. Howard, Mark.R. Dadds, Philip Mitchell and Dean S. Carson
Psychoneuroendocrinology. Volume 34, Issue 6, July 2009, Pages 917-923
3! - A review of the natural course of bipolar
disorders (manic–depressive psychosis) in the pre-drug era: Review of studies
prior to 1950
M. Alvarez Ariza,
R. Mateos Alvarez and G.E. Berrios
Journal of Affective Disorders. Volume 115, Issue
3, June 2009, Pages 293-301
3! - Cardiovascular risk in patients with bipolar
disorder
Maria P.
Garcia-Portilla, Pilar A. Saiz, Maria T. Bascaran, Sara Martínez, Antonio
Benabarre, Pilar Sierra, Pedro Torres, Jose Manuel Montes, Manuel Bousoño,
Julio Bobes and on behalf of the General Health Status in Bipolar Disorder
Collaborative Group
Journal of Affective Disorders. Volume 115, Issue
3, June 2009, Pages 302-308
3! - The relationship of bulimia and anorexia nervosa
with bipolar disorder and its temperamental foundations
Anna V. Lunde, Ole
B. Fasmer, Kareen K. Akiskal, Hagop S. Akiskal and Ketil J. Oedegaard
Journal of Affective Disorders. Volume 115, Issue
3, June 2009, Pages 309-314
3! - A prospective study of the impact of comorbid
medical disease on bipolar disorder outcomes
Paul A. Pirraglia,
Kousick Biswas, Amy M. Kilbourne, Howard Fenn and Mark S. Bauer
Journal of Affective Disorders. Volume 115, Issue
3, June 2009, Pages 355-359
3! - Self-medication of mood disorders with alcohol and
drugs in the National Epidemiologic Survey on Alcohol and Related Conditions
James M. Bolton,
Jennifer Robinson and Jitender Sareen
Journal of Affective Disorders. Volume 115, Issue
3, June 2009, Pages 367-375
5 - Randomized, placebo-controlled trial of
risperidone for acute treatment of bipolar anxiety
David V. Sheehan,
Susan L. McElroy, Kathy Harnett-Sheehan, Paul E. Keck Jr., Juris Janavs, Jamison
Rogers, Robert Gonzalez, Geetha Shivakumar and Trisha Suppes
Journal of Affective Disorders. Volume 115, Issue
3, June 2009, Pages 376-385
3! - Does early improvement triggered by antidepressants
predict response/remission? — Analysis of data from a naturalistic study on a
large sample of inpatients with major depression
Verena Henkel,
Florian Seemüller, Michael Obermeier, Mazda Adli, Michael Bauer, Christoph
Mundt, Peter Brieger, Gerhard Laux, Wolfram Bender, Isabella Heuser, Joachim
Zeiler, Wolfgang Gaebel, Andreas Mayr, Hans-Jürgen Möller and Michael Riedel
Journal of Affective Disorders. Volume 115, Issue
3, June 2009, Pages 439-449
3! - The three-year naturalistic course of major
depressive disorder, dysthymic disorder and double depression
Didi Rhebergen,
Aartjan TF Beekman, Ron de Graaf, Willem A. Nolen, Jan Spijker, Witte J.
Hoogendijk and Brenda WJH Penninx
Journal
of Affective Disorders. Volume 115, Issue 3, June 2009, Pages 450-459
3 - Risk of Fractures with Selective Serotonin-Reuptake
Inhibitors or Tricyclic Antidepressants
Regina
Ginzburg, Enma Rosero
The
Annals of Pharmacotherapy: Vol. 43, No. 1, pp. 98-103
GRATIS 3! - Predictors of nonresponse
to cognitive behavioural therapy or venlafaxine using glucose metabolism in
major depressive disorder
Jakub Z. Konarski, Sidney H. Kennedy, Zindel
V. Segal, Mark A. Lau, Peter J. Bieling, Roger S. McIntyre, Helen S. Mayberg
J Psychiatry Neurosci 2009;34(3):175-80
GRATIS 3! - Effects of sustained
serotonin reuptake inhibition on the firing of dopamine neurons in the rat
ventral tegmental area
Eliyahu Dremencov, Mostafa El Mansari, Pierre Blier
J Psychiatry Neurosci 2009;34(3):223-9
GRATIS 3! - Incidence of Major
Malformations in Infants Following Antidepressant Exposure in Pregnancy:
Results of a Large Prospective Cohort Study
Adrienne Einarson, Jacquelyn Choi, Thomas R
Einarson, Gideon Koren
Can J Psychiatry. 2009;54(4):242–246
GRATIS 3 - Treatment-Resistant Depression -- Part III: Switching
Antidepressants vs. Conventional Augmentation Strategies
George I. Papakostas
Psychiatry Weekly, April
27, 2009
GRATIS 3 - When to Avoid Antidepressants in Bipolar Patients
Kenneth J. Bender
Psychiatric Times 2009. Vol. 26 No. 4
3 – Differential Efficacy of memantine for
Obsessive-Compulsive Disorder vs. Generalized Anxiety Disorder: An Open label
Trial
Feusner JD et al.
Psychopharmacol Bull 2009;
42: 81-93
4 – Early Symptom Change Prediction of Remission
in Depression Treatment
Katz MM et al.
Psychopharmacol Bull 2009;
42: 94-107
| Regresar a RESÚMENES ABRIL 2009 |